VIRC Wins Regenerative Medicine Research Awards at National Conference
UC Davis’ Veterinary Institute for Regenerative Cures (VIRC) recently attended the North American Veterinary Regenerative Medicine Association Conference at Colorado State University’s C. Wayne Mcllwraith Translational Medical Institute. VIRC’s award-winning presence at the conference included five podium lectures and three research poster presentations.
“This sizable presence at the conference and our research contributions are an indication and example of VIRC’s impact, leadership, and reputation nationally and internationally in the field of regenerative medicine,” said Dr. Boaz Arzi, director of VIRC.
Dr. Arzi was honored with the Boehringer Ingelheim Translational Medicine Award, which honors the research presentation that has the highest translational potential. The award also includes a $5,000 research grant. Kaitlin Clark from the Wang Laboratory won two competitive awards: best research poster presentation and best oral presentation.
Podium lectures at the conference included:
- Kaitlin Clark (Wang Laboratory): Comparison of canine placenta and adipose-derived mesenchymal stem/stromal cells immunomodulatory properties: applications to inflammatory brain disease
- Dr. Boaz Arzi: Ten years of bone regeneration in dogs using rhBMP2: what have we learned so far?
- Dr. Natalia Vapniarsky: Tissue engineering of canine cartilage from surgically debrided osteochodritis dissecans fragments
- Dr. Amir Kol: Canine induced pluripotent stem cells - state of the field
- Charles Crawford (Kol Laboratory): Inflammatory cytokines induce epithelial barrier dysfunction in a bovine intestinal organoid model
Research poster presentations included:
- Arzi B. et al: A Multicenter Experience Using Adipose-Derived Stromal Cell Therapy for Cats with Chronic, Non-Responsive Gingivostomatitis
- Clark K. et al: Evaluation of Canine Placenta-derived Mesenchymal Stem/Stromal Cells as a Postnatal Therapy for the Treatment of Spina Bifida in English Bulldogs: A Clinical Trial Update
- Cassano J. et al. Evaluating Safety and Migration of Subconjunctival Poly I:C-activated Equine Mesenchymal Stromal Cell Therapy